DexCom Gross Profit 2010-2024 | DXCM

DexCom annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • DexCom gross profit for the quarter ending December 31, 2024 was $0.656B, a 0.12% decline year-over-year.
  • DexCom gross profit for the twelve months ending December 31, 2024 was $2.438B, a 6.52% increase year-over-year.
  • DexCom annual gross profit for 2024 was $2.438B, a 6.52% increase from 2023.
  • DexCom annual gross profit for 2023 was $2.289B, a 21.55% increase from 2022.
  • DexCom annual gross profit for 2022 was $1.883B, a 12.06% increase from 2021.
DexCom Annual Gross Profit
(Millions of US $)
2024 $2,438
2023 $2,289
2022 $1,883
2021 $1,681
2020 $1,280
2019 $932
2018 $664
2017 $492
2016 $378
2015 $278
2014 $176
2013 $100
2012 $47
2011 $36
2010 $18
2009 $4
DexCom Quarterly Gross Profit
(Millions of US $)
2024-12-31 $656
2024-09-30 $594
2024-06-30 $627
2024-03-31 $562
2023-12-31 $657
2023-09-30 $623
2023-06-30 $546
2023-03-31 $463
2022-12-31 $541
2022-09-30 $494
2022-06-30 $450
2022-03-31 $398
2021-12-31 $473
2021-09-30 $447
2021-06-30 $417
2021-03-31 $344
2020-12-31 $399
2020-09-30 $340
2020-06-30 $284
2020-03-31 $257
2019-12-31 $309
2019-09-30 $247
2019-06-30 $207
2019-03-31 $169
2018-12-31 $223
2018-09-30 $169
2018-06-30 $154
2018-03-31 $119
2017-12-31 $154
2017-09-30 $127
2017-06-30 $118
2017-03-31 $94
2016-12-31 $117
2016-09-30 $101
2016-06-30 $86
2016-03-31 $75
2015-12-31 $91
2015-09-30 $75
2015-06-30 $66
2015-03-31 $47
2014-12-31 $59
2014-09-30 $47
2014-06-30 $40
2014-03-31 $30
2013-12-31 $34
2013-09-30 $28
2013-06-30 $22
2013-03-31 $17
2012-12-31 $18
2012-09-30 $8
2012-06-30 $11
2012-03-31 $9
2011-12-31 $11
2011-09-30 $8
2011-06-30 $12
2011-03-31 $5
2010-12-31 $7
2010-09-30 $3
2010-06-30 $5
2010-03-31 $3
2009-12-31 $4
2009-09-30 $1
2009-06-30 $-1
2009-03-31 $-0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $26.777B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $187.725B 22.76
Intuitive Surgical (ISRG) United States $176.405B 80.93
Alcon (ALC) Switzerland $46.824B 31.12
Edwards Lifesciences (EW) United States $42.608B 27.66
IDEXX Laboratories (IDXX) United States $34.032B 39.36
IQVIA Holdings (IQV) United States $31.084B 17.20
Mettler-Toledo (MTD) United States $24.611B 28.69
STERIS (STE) Ireland $22.269B 25.47
Waters (WAT) United States $21.897B 31.05
SONOVA HOLDING (SONVY) Switzerland $17.380B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.612B 14.91
Hologic (HOLX) United States $13.861B 14.96
Sysmex ADR (SSMXY) Japan $11.941B 37.44
Penumbra (PEN) United States $10.300B 93.17
Globus Medical (GMED) United States $10.068B 23.31
Masimo (MASI) United States $9.002B 37.78
Teleflex (TFX) United States $6.407B 9.86
Glaukos (GKOS) United States $5.567B 0.00
Integer Holdings (ITGR) United States $3.967B 22.27
PROCEPT BioRobotics (PRCT) United States $3.194B 0.00
Veracyte (VCYT) United States $2.311B 41.76
TransMedics (TMDX) United States $2.265B 66.61
Nihon Kohden (NHNKY) Japan $2.205B 12.06
LivaNova (LIVN) United Kingdom $2.135B 12.96
Elekta AB (EKTAY) Sweden $1.995B 17.93
Integra LifeSciences Holdings (IART) United States $1.698B 8.59
Alphatec Holdings (ATEC) United States $1.462B 0.00
Tandem Diabetes Care (TNDM) United States $1.274B 0.00
OPKO Health (OPK) United States $1.115B 0.00
Paragon 28 (FNA) United States $1.096B 0.00
Artivion (AORT) United States $1.034B 98.32
RxSight (RXST) United States $1.022B 0.00
Pulse Biosciences (PLSE) United States $0.990B 0.00
AxoGen (AXGN) United States $0.820B 0.00
IRadimed (IRMD) United States $0.667B 34.99
AVANOS MEDICAL, INC (AVNS) United States $0.659B 10.61
Mesa Laboratories (MLAB) United States $0.645B 14.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.636B 0.00
OrthoPediatrics (KIDS) United States $0.598B 0.00
SiBone (SIBN) United States $0.596B 0.00
Beta Bionics (BBNX) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.525B 0.00
Delcath Systems (DCTH) United States $0.425B 0.00
NeuroPace (NPCE) United States $0.400B 0.00
AngioDynamics (ANGO) United States $0.380B 0.00
Pacific Biosciences Of California (PACB) United States $0.351B 0.00
Semler Scientific (SMLR) United States $0.347B 7.37
ClearPoint Neuro (CLPT) United States $0.329B 0.00
CVRx (CVRX) United States $0.318B 0.00
Tactile Systems Technology (TCMD) United States $0.313B 16.73
Nevro (NVRO) United States $0.224B 0.00
Inogen (INGN) United States $0.192B 0.00
Accuray (ARAY) United States $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.177B 0.00
LENSAR (LNSR) United States $0.166B 0.00
908 Devices (MASS) United States $0.158B 0.00
Spectral Diagnostics (EDTXF) Canada $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Sight Sciences (SGHT) United States $0.123B 0.00
KORU Medical Systems (KRMD) United States $0.117B 0.00
Rapid Micro Biosystems (RPID) United States $0.114B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Atossa Genetics (ATOS) United States $0.087B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
Sensus Healthcare (SRTS) United States $0.078B 11.82
EDAP TMS S.A (EDAP) France $0.073B 0.00
Zomedica (ZOMDF) United States $0.057B 0.00
Hyperfine (HYPR) United States $0.056B 0.00
Microbot Medical (MBOT) United States $0.052B 0.00
EnVVeno Medical (NVNO) United States $0.046B 0.00
Vicarious Surgical (RBOT) United States $0.039B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.027B 0.00
Envoy Medical (COCH) United States $0.026B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
NexGel (NXGL) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Aspira Women's Health (AWH) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00